Biofrontera AG/ DE000A4BGGM7 /
| - - | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| -EUR | - | - Turnover: - |
-Bid Size: - | -Ask Size: - | 8.37 mill.EUR | - | - |
Assets
| 2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | .6000 | .7000 | .8000 | 5.2000 | 5.1000 | ||||||
| Intangible Assets | 1.3000 | .6000 | .4000 | 22.8000 | 17.7000 | ||||||
| Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Fixed Assets | 1.9000 | 1.4000 | 11.5000 | 35.9000 | 30.3000 | ||||||
| Inventories | 3.6000 | 3.7000 | 3.2000 | 4.1000 | 4.7000 | ||||||
| Accounts Receivable | 1.6000 | 1.6000 | 3.4000 | 5 | 3.5000 | ||||||
| Cash and Cash Equivalents | 15.1000 | 11.1000 | 19.5000 | 11.1000 | 16.5000 | ||||||
| Current Assets | 22 | 18.5000 | 27.6000 | 22.5000 | 26.1000 | ||||||
| Total Assets | 23.9000 | 19.8000 | 39.1000 | 58.4000 | 56.4000 | ||||||
Liabilities
| 2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 2.1000 | 1.1000 | 1.8000 | 4.2000 | 1.6000 | ||||||
| Long-term debt | 3.6000 | 12.4000 | 13.5000 | 36.8000 | 40.7000 | ||||||
| Liabilities to Banks | 3.9000 | 12.6000 | 13.7000 | 38.1000 | 41.9000 | ||||||
| Provisions | 1.8000 | 2.5000 | 5.8000 | 6.1000 | 5.4000 | ||||||
| Liabilities | 8 | 16.5000 | 22.8000 | 48.4000 | 49 | ||||||
| Share Capital | 37.7220 | 38.4170 | 44.6320 | 44.8490 | 47.7480 | ||||||
| Total Equity | 15.8000 | 3.4000 | 16.4000 | 10 | 7.4000 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 23.9000 | 19.8000 | 39.1000 | 58.4000 | 56.4000 | ||||||
Income Statement
| 2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 6.1000 | 12 | 21.1000 | 31.3000 | 30.3000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -11.8000 | -13.9000 | -18.5000 | -23.4000 | -7.6000 | ||||||
| Interest Income | -1.1970 | -1.0620 | -1.7760 | -2.6000 | -2.7000 | ||||||
| Income Before Taxes | -10.6000 | -16.1000 | -19.3000 | -4.8000 | -12.7000 | ||||||
| Income Taxes | 0.0000 | 0.0000 | -10.4000 | 2.6000 | .3000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -10.6000 | -16.1000 | -8.9000 | -7.4000 | -13 | ||||||
Per Share
Cash Flow
| 2016 IFRS in mill. EUR |
2017 IFRS in mill. EUR |
2018 IFRS in mill. EUR |
2019 IFRS in mill. EUR |
2020 IFRS in mill. EUR |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -10.7000 | -13.1000 | -13.4000 | -32.9000 | -2.8000 | ||||||
| Cash Flow from Investing Activities | -.5000 | -.4000 | -.5000 | 21.1000 | 2.9000 | ||||||
| Cash Flow from Financing | 22.4000 | 9.5000 | 22.3000 | 3.5000 | 5.9000 | ||||||
| Decrease / Increase in Cash | 11.2000 | -4 | 8.3000 | -8.4000 | 6 | ||||||
| Employees | 94 | 119 | 141 | 180 | 157 | ||||||
